Prognostic Value of the Systemic Immune-Inflammation Index (SII) After Neoadjuvant Therapy for Patients with Resected Pancreatic Cancer

BACKGROUND. The systemic immune-inflammation index (SII), calculated using absolute platelet, neutrophil, and lymphocyte counts, has recently emerged as a predictor of survival for patients with pancreatic ductal adenocarcinoma (PDAC) when assessed at diagnosis. Neoadjuvant therapy (NAT) is increasi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Surg Oncol
Hlavní autoři: Murthy, Pranav, Zenati, Mazen S., Al Abbas, Amr I., Rieser, Caroline J., Bahary, Nathan, Lotze, Michael T., Zeh, Herbert J., Zureikat, Amer H., Boone, Brian A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7879583/
https://ncbi.nlm.nih.gov/pubmed/31792715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-019-08094-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky